Brevetti
Il laboratorio è detentore di alcuni brevetti relativi alla ricerca e lo sviluppo di antivirali e di nanotecnologie:
(2009) Novel antiviral peptides, n° brevetto: MI2009A001425.
(2012) Novel antipathogenic peptides, n° brevetto: US 2012/0121623 A1.
(2011) Novel antipathogenic peptides, n° brevetto: WO/2011/015628.
(2012) 䐾合保温防火板, n° brevetto: CN 201110316296.4.
(2011) Membrane for nanocapsule, nanocapsule comprising the same and its use, n° brevetto: TO2011A000884.
(2016) Oxisterols for use in the treatment and prevention of diseases caused by viruses, n° brevetto WO2016001870 A1.
(2021) Oxisterol for use in the treatment and prevention of pathologies caused by coronaviruses, n° brevetto: PCT IB2021053421.
